HOME >> BIOLOGY >> NEWS
Jefferson researchers develop combined procedure for uterine preservation in treating fibroids

Although fibroidsbenign tumors that grow in the uteruscan cause pelvic pain, abnormal vaginal bleeding and infertility, women of childbearing age often choose to forego treatment because the available treatment options dont guarantee fertility.

In a study in the December issue of The Female Patient, physicians at Thomas Jefferson University Hospital in Philadelphia present a case history of a 35-year-old women whose numerous fibroids formed a large mass in her pelvic area that, when initially diagnosed, was of a size comparable to a full-term pregnancy.

"Traditionally, treatment for such a large fibroid mass in the uterus has been limited to hysterectomy, because the patient would bleed extensively if an attempt was made to merely remove the fibroids." says Jay Goldberg, M.D., MSCP, lead author and director of the Jefferson Fibroid Center at Thomas Jefferson University. "In this particular case though, hysterectomy was not an option because the patient strongly desired future fertility and uterine preservation."

To meet the patients wishes and remove the fibroids, the physicians developed a plan to perform two procedures a month apart.

The Jefferson physicians first performed a uterine fibroid embolization (UFE), a minimally invasive radiologic procedure that blocks the arteries that supply blood to the fibroid tumors. The procedure was done to reduce the blood flow within the patients uterus and the risk of hemorrhaging at the time of surgery.

One month later, the patient underwent an abdominal myomectomy. In this procedure, the fibroids are removed through an abdominal skin incision. After the UFE, her initially 38-week sized uterus had decreased to a 34-week size, with decreased blood flow. Eleven large fibroids were removed during the myomectomy, with minimal blood loss. The patient was discharged from the hospital on the second day post-surgery and experienced no complications.

Dr. Goldberg,
'"/>

Contact: Nan Myers
nan.myers@jefferson.edu
215-955-6300
Thomas Jefferson University
5-Dec-2006


Page: 1 2

Related biology news :

1. Jefferson scientists patent dramatically improves
2. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
3. Tiny genes may increase cancer susceptibility, Jefferson scientists find
4. Jefferson scientists use gene therapy to reverse heart failure in animals
5. Jefferson researchers discovery may change thinking on how viruses invade the brain
6. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
7. Jefferson scientists find rabies-based vaccine could be effective against HIV
8. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer
9. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
10. Jefferson scientists find guardian genes choices crucial to stopping cancer process
11. Jefferson researchers uncover new way nature turns genes on and off

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 02, 2020 , ... ... a publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to ... in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for the ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for the fall ... Care Testing solutions (POCT). Check local listings for more info. , Today, the majority ... are shipped to labs throughout the country. Results are then available several days later. ...
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation of ... assays (LBA) have dominated this area. However, the use of mass spectrometry in this ... now necessitates the question “How do you choose which approach to use (LBA or ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing ... announced that they have entered into a strategic partnership whereby Catalent will provide ...
(Date:7/22/2020)... TORONTO (PRWEB) , ... July 22, 2020 , ... Join ... and John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... is the regulating body in China for drugs and medical devices. Specifically, for medical ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Charles Galea has ... Business Development. , Charles is an accomplished and results-driven sales executive with over ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, ... the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor ...
Breaking Biology Technology:
Cached News: